tert-butyl N-(2-fluoro-5-{5-[2-(methoxymethyl)-2'-methylbiphenyl-4-yl]-1,2,4-oxadiazol-3-yl}benzyl)-N-methyl-beta-alaninate → N-(3-{5-[2-(methoxymethyl)-2'-methylbiphenyl-4-yl]-1,2,4-oxadiazol-3-yl}benzyl)-N-methyl-beta-alanine
Reaction equation
F[C:2]1[CH:19]=[CH:18][C:17]([C:20]2[N:24]=[C:23]([C:25]3[CH:30]=[CH:29][C:28]([C:31]4[CH:36]=[CH:35][CH:34]=[CH:33][C:32]=4[CH3:37])=[C:27]([CH2:38][O:39][CH3:40])[CH:26]=3)[O:22][N:21]=2)=[CH:16][C:3]=1[CH2:4][N:5]([CH3:15])[CH2:6][CH2:7][C:8]([O:10]C(C)(C)C)=[O:9]>Cl.O1CCOCC1>[CH3:40][O:39][CH2:38][C:27]1[CH:26]=[C:25]([C:23]2[O:22][N:21]=[C:20]([C:17]3[CH:16]=[C:3]([CH:2]=[CH:19][CH:18]=3)[CH2:4][N:5]([CH3:15])[CH2:6][CH2:7][C:8]([OH:10])=[O:9])[N:24]=2)[CH:30]=[CH:29][C:28]=1[C:31]1[CH:36]=[CH:35][CH:34]=[CH:33][C:32]=1[CH3:37]Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
tert-butyl N-(2-fluoro-5-{5-[2-(methoxymethyl)-2′-methylbiphenyl-4-yl]-1,2,4-oxadiazol-3-yl}benzyl)-N-methyl-beta-alaninate obtained in step 1 was dissolved in HCl in dioxane (4M, 10 mL), stirred at RT for 30 h. After this time, solvents were removed under vacuum, residue was triturated with Et2O and filtered to give the title compound as an off-white powder. 1H NMR (DMSO-d6, 300 MHz) δ 12.74 (bs, 1H), 10.38 (bs, 1H), 8.36-8.33 (m, 1H), 8.23-8.20 (m, 1H), 8.18-8.15 (m, 1H), 7.87-7.84 (m, 1H), 7.72 (t, J=7.8 Hz, 1H), 7.44 (d, J=7.9 Hz, 1H), 7.37-7.28 (m, 3H), 7.15-7.13 (m, 1H), 4.48 (bs, 2H), 4.23 (d, J=12.7 Hz, 1H), 4.16 (d, J=12.7 Hz, 1H), 3.25 (s, 3H), 2.89-2.84 (m, 2H), 2.70 (s, 3H), 2.03 (s, 3H). LC/MS (Method B): 472.4 (M+H)+. HPLC (Method A) Rt 4.53 min (purity: 97.4%).
Workup
- customAfter this time, solvents were removed under vacuum, residue
- customwas triturated with Et2O
- filtrationfiltered
Sources & evidence
- ORD record
- ord-d60a560635964a3b8c9147bb712a987f
- Source dataset
- uspto-grants-2012_06
- Patent number
- US08202865B2
Reaction notes
Loading…